Consider TLR5 for new therapeutic development against COVID-19

被引：47
作者：
Chakraborty, Chiranjib [1 ,2 ]
Sharma, Ashish Ranjan [2 ]
Bhattacharya, Manojit [2 ]
Sharma, Garima [3 ]
Lee, Sang-Soo [2 ]
Agoramoorthy, Govindasamy [4 ]
机构：
[1] Adamas Univ, Sch Life Sci & Biotechnol, Dept Biotechnol, Barasat Barrackpore Rd, Kolkata 700126, W Bengal, India
[2] Hallym Univ, Inst Skeletal Ageing & Orthoped Surg, Chuncheon Sacred Heart Hosp, Chuncheon Si, Gangwon Do, South Korea
[3] Kangwon Natl Univ, Coll Pharm, Neuropsychopharmacol & Toxicol Program, Chunchon, South Korea
[4] Tajen Univ, Coll Pharm & Hlth Care, Pingtung 907, Taiwan
来源：
JOURNAL OF MEDICAL VIROLOGY | 2020年 / 92卷 / 11期
关键词：
COVID-19; therapeutic development; TLR5; INNATE;
D O I：
10.1002/jmv.25997
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
引用
收藏
页码：2314 / 2315
页数：2
相关论文
共 13 条
[1]   Development of epitope-based peptide vaccine against novel coronavirus 2019 (SARS-COV-2): Immunoinformatics approach [J].
Bhattacharya, Manojit ;
Sharma, Ashish R. ;
Patra, Prasanta ;
Ghosh, Pratik ;
Sharma, Garima ;
Patra, Bidhan C. ;
Lee, Sang-Soo ;
Chakraborty, Chiranjib .
JOURNAL OF MEDICAL VIROLOGY, 2020, 92 (06) :618-631
[2]   Frontline Science: Nasal epithelial GM-CSF contributes to TLR5-mediated modulation of airway dendritic cells and subsequent IgA response [J].
Cao, Yuan ;
Zhang, Ejuan ;
Yang, Jingyi ;
Yang, Yi ;
Yu, Jie ;
Xiao, Yang ;
Li, Wei ;
Zhou, Dihan ;
Li, Yaoming ;
Zhao, Bali ;
Yan, Hu ;
Lu, Mengji ;
Zhong, Maohua ;
Yan, Huimin .
JOURNAL OF LEUKOCYTE BIOLOGY, 2017, 102 (03) :575-587
[3]   Utilizing a TLR5-Adjuvanted Cytomegalovirus as a Lentiviral Vaccine in the Nonhuman Primate Model for AIDS [J].
Deere, Jesse D. ;
Chang, W. L. William ;
Castillo, Luis D. ;
Schmidt, Kim A. ;
Kieu, Hung T. ;
Renzette, Nicholas ;
Kowalik, Timothy ;
Barthold, Stephen W. ;
Shacklett, Barbara L. ;
Barry, Peter A. ;
Sparger, Ellen E. .
PLOS ONE, 2016, 11 (05)
[4]   Toll-like receptor 5 agonist flagellin reduces influenza A virus replication independently of type I interferon and interleukin 22 and improves antiviral efficacy of oseltamivir [J].
Georgel, Anne-France ;
Cayet, Delphine ;
Pizzorno, Andres ;
Rosa-Calatrava, Manuel ;
Paget, Christophe ;
Sencio, Valentin ;
Dubuisson, Jean ;
Trottein, Francois ;
Sirard, Jean-Claude ;
Carnoy, Christophe .
ANTIVIRAL RESEARCH, 2019, 168 :28-35
[5]   Harnessing innate immunity to eliminate SARS-CoV-2 and ameliorate COVID-19 disease [J].
Golonka, Rachel M. ;
Saha, Piu ;
Yeoh, Beng San ;
Chattopadhyay, Saurabh ;
Gewirtz, Andrew T. ;
Joe, Bina ;
Vijay-Kumar, Matam .
PHYSIOLOGICAL GENOMICS, 2020, 52 (05) :217-221
[6]   Microneedle array delivered recombinant coronavirus vaccines: Immunogenicity and rapid translational development [J].
Kim, Eun ;
Erdos, Geza ;
Huang, Shaohua ;
Kenniston, Thomas W. ;
Balmert, Stephen C. ;
Carey, Cara Donahue ;
Raj, V. Stalin ;
Epperly, Michael W. ;
Klimstra, William B. ;
Haagmans, Bart L. ;
Korkmaz, Emrullah ;
Falo, Louis D., Jr. ;
Gambotto, Andrea .
EBIOMEDICINE, 2020, 55
[7]   A West Nile virus recombinant protein vaccine that coactivates innate and adaptive immunity [J].
McDonald, William F. ;
Huleatt, James W. ;
Foellmer, Harald G. ;
Hewitt, Duane ;
Tang, Jie ;
Desai, Priyanka ;
Price, Albert ;
Jacobs, Andrea ;
Takahashi, Virginia N. ;
Huang, Yan ;
Nakaar, Valerian ;
Alexopoulou, Lena ;
Fikrig, Erol ;
Powell, T. J. .
JOURNAL OF INFECTIOUS DISEASES, 2007, 195 (11) :1607-1617
[8]  
Mehta P, 2020, LANCET, V6736, P19
[9]   TLR agonists as modulators of the innate immune response and their potential as agents against infectious disease [J].
Mifsud, Edin J. ;
Tan, Amabel C. L. ;
Jackson, David C. .
FRONTIERS IN IMMUNOLOGY, 2014, 5 :1-10
[10]   Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China [J].
Qin, Chuan ;
Zhou, Luoqi ;
Hu, Ziwei ;
Zhang, Shuoqi ;
Yang, Sheng ;
Tao, Yu ;
Xie, Cuihong ;
Ma, Ke ;
Shang, Ke ;
Wang, Wei ;
Tian, Dai-Shi .
CLINICAL INFECTIOUS DISEASES, 2020, 71 (15) :762-768
12